Mesh AI
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Mesh AI
May 28, 2024, 15:08 |
Opinion
Roupen Odabashian: We should have a universal test to screen for many cancers at once
Roupen Odabashian shared on LinkedIn: "Every cancer should have a screening test, or let’s put…
May 27, 2024, 12:23 |
Blog
Roupen Odabashian: The biggest joy and the biggest frustration in being an oncologist
Roupen Odabashian shared on LinkedIn: "The biggest joy and the biggest frustration in being an…
Aug 23, 2023, 17:32 |
Career
Roupen Odabashian: I'm happy to share that I'm starting a new position as an Advisor at Mesh AI!
Roupen Odabashian, a Hematology/Oncology Fellow at Karmanos Cancer Institute in Detroit, recently shared on LinkedIn.…
All:
3
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube